20161 ⎘
Medicinal preparations characterised by special physical form; Preparations in capsules, e.g. of gelatin, of chocolate; Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to or , e.g. for obtaining a specific release pattern or for combining different drugs
Pharmaceutical dosage forms having immediate and controlled release properties that contain a GABAB receptor agonist
#902Pharmaceutical dosage forms having controlled release properties that contain a GABAB receptor agonist
#903Methods and compositions for improving drug safety
#904Gastrointestinal-specific multiple drug release system
#905Medicaments containing active ingredients which lower the level of cholesterol with time-delayed active ingredient release
#906Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
#907Abuse-resistant pharmaceutical dosage form
#908Tamper-resistant oral opioid agonist formulations
#909Sustained release oral formulations
#910Alprazolam formulations
#911Controlled release formulations of opioid and nonopioid analgesics
#912Dynamic variable release
#913Controlled release oral dosage form
#914Systems, methods and apparatuses for manufacturing dosage forms
#915Systems, methods and apparatuses for manufacturing dosage forms
#916Pantoprazole multiparticulate formulations
#917Method and apparatus for transferring substrates
#918Compositions of quaternary ammonium compounds containing bioavailability enhancers
#919Method of treating attention deficit disorders with D-threo methylphenidate
#920Timed pulsatile drug delivery systems
#921Drug coating providing high drug loading
#922Extended release venlafaxine formulation
#923Controlled release analgesic suspensions
#924Controlled release analgesic suspensions
#925Tamper-resistant oral opioid agonist formulations
#926Pharmaceutical formulation for the active ingredient budesonide
#927Oros push-stick for controlled delivery of active agents
#928Pharmaceutical formulations containing combinations of epinastine, pseudoephedrine, and methylephedrine
#929Extended release formulations of opioids and method of use thereof
#930Compositions containing both sedative and non-sedative antihistamines and sleep aids
#931Microcapsules having multiple shells and method for the preparation thereof
#932Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
#933Oral extended-release composition
#934Oral dosage form comprising a therapeutic agent and an adverse-effect agent
#935Antibiotic product, use and formulation thereof
#936Capsule containing active substance pellets
#937Multi-particulate form of medicament, comprising at least two differently coated forms of pellet
#938Chronic, bolus administration of D-threo methylphenidate
#939Antibiotic product, use and formulation thereof
#940Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders
#941Dosage forms of cholesteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors
#942Antibiotic product, use and formulation thereof
#943Spray drying processes for forming solid amorphous dispersions of drugs and polymers
#944Methods and devices for providing prolonged drug therapy
#945Methods and devices for providing prolonged drug therapy
#946Pulsatile release histamine H2 antagonist dosage form
#947Sustained release opioid formulations and method of use
#948Composite dosage forms
#949Antibiotic product, use and formulation thereof
#950Formulation for lacosamide
#951Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
#952Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
#953Method of lubricating bodily tissue using an amnion derived therapeutic composition
#954Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
#955Extended release pharmaceutical composition of Clozapine
#956Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
#957Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
#958Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
#959Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
#960Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
#961Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
#962Duloxetine sprinkles
#963Pharmaceutical product comprising a sequestered agent
#964Timed, sustained release systems for propranolol
#965Drug formulations having reduced abuse potential